Comment

The Advisory Council for the Misuse of Drugs' recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow...

Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA. UNDER a...

Leading cannabis Lawyer Robert Jappie of law firm Ince reflects on the shifting status of CBD in Europe THE European Commission has paused consideration of...

Alex Fraser, Patient Access Lead with Grow Pharma, on the recently-launched 'Open Cannabis' campaign THE truth is there are a huge number of patients...

AUSTRIAN seed-to-sale CBD firm MAGU says the future looks brighter under a new cannabis-friendly Government. Co-Founder Sofie Sagmeister elaborates. “COVID-19 has hit us hard -...

AS the KanaVape case awaits European Court of Justice (ECJ) ratification its implications for the hemp and CBD markets across the continent...

BEFORE heading off to Greece to persuade its politicians to commit to the cannabis industry, former Canopy Growth Chief Executive Bruce Linton elaborated on...